Cargando…
Variation in topoisomerase I gene copy number as a mechanism for intrinsic drug sensitivity.
DNA topoisomerase I (topo I) is the principle target for camptothecin and its derivatives such as SN38. Levels of topo I expression vary widely between and within tumour types and the basis for this is poorly understood. We have used fluorescence in situ hybridisation to detect the topo I locus in a...
Autores principales: | McLeod, H. L., Keith, W. N. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074660/ https://www.ncbi.nlm.nih.gov/pubmed/8761363 |
Ejemplares similares
-
Mechanisms of Topoisomerase I (TOP1) Gene Copy Number Increase in a Stage III Colorectal Cancer Patient Cohort
por: Smith, David Hersi, et al.
Publicado: (2013) -
Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer
por: Palshof, Jesper Andreas, et al.
Publicado: (2017) -
RNAseqCNV: analysis of large-scale copy number variations from RNA-seq data
por: Bařinka, Jan, et al.
Publicado: (2022) -
Analysis of copy number variations and possible candidate genes in spontaneous abortion by copy number variation sequencing
por: Bai, Wei, et al.
Publicado: (2023) -
Plasmodium copy number variation scan: gene copy numbers evaluation in haploid genomes
por: Beghain, Johann, et al.
Publicado: (2016)